Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

Preconditioning strategies for stem cells and exosomes: Transformative potential in diabetic wound treatment: A review.

Zhao H., Yang K., Wang X., Qiao Z., Wu J., Yu Z.

Narrative Review on Diabetic Foot, Chronic Wound, published in Int J Biol Macromol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Int J Biol Macromol (2025)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
41352497
DOI
10.1016/j.ijbiomac.2025.149504

Abstract (original English)

Diabetic wounds pose a significant clinical challenge due to impaired healing processes driven by poor circulation, neuropathy, and immune dysfunction. Adipose-derived stem cells (ADSCs) and mesenchymal stem cells (MSCs) offer promising therapeutic potential due to their multilineage differentiation and paracrine effects that promote tissue regeneration. However, the harsh wound environment necessitates innovative strategies to enhance their therapeutic efficacy. This review explores various preconditioning strategies, including hypoxic, pharmacological, cytokine, and carrier systems, that enhance the survival, proliferation, and function of ADSCs and MSCs. The integration of advanced biomaterials such as hydrogels and scaffolds further supports cell viability and function, offering potential solutions for improved diabetic wound healing. Recent advances and future directions in the optimization of these strategies are discussed, emphasizing their potential to transform stem cell therapies for diabetic wounds. We highlight that specific preconditioning methods-such as hypoxia and pharmacological agents like metformin or empagliflozin-can selectively enhance exosomal miRNA cargo (e.g., miR-126, miR-139-3p) and downstream angiogenic signaling.Our synthesis underscores the superior translational potential of ADSC-derived exosomes over cell therapies, especially when optimized via

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansExosomesWound HealingAnimalsStem CellsMesenchymal Stem CellsDiabetes MellitusAdipose TissueMicroRNAs

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research